PNC Financial Services Group’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.72K | Sell |
504
-1,640
| -76% | -$15.4K | ﹤0.01% | 4161 |
|
|
2025
Q1 | $26.3K | Buy |
2,144
+233
| +12% | +$2.86K | ﹤0.01% | 3414 |
|
|
2024
Q4 | $25.3K | Sell |
1,911
-500
| -21% | -$6.61K | ﹤0.01% | 3424 |
|
|
2024
Q3 | $46.4K | Buy |
2,411
+902
| +60% | +$17.4K | ﹤0.01% | 3133 |
|
|
2024
Q2 | $31K | Buy |
1,509
+546
| +57% | +$11.2K | ﹤0.01% | 3273 |
|
|
2024
Q1 | $22.9K | Sell |
963
-15
| -2% | -$357 | ﹤0.01% | 3381 |
|
|
2023
Q4 | $21.1K | Buy |
978
+818
| +511% | +$17.7K | ﹤0.01% | 3400 |
|
|
2023
Q3 | $2.32K | Buy |
160
+62
| +63% | +$901 | ﹤0.01% | 4200 |
|
|
2023
Q2 | $2.05K | Hold |
98
| – | – | ﹤0.01% | 4374 |
|
|
2023
Q1 | $2.07K | Hold |
98
| – | – | ﹤0.01% | 4302 |
|
|
2022
Q4 | $2.49K | Hold |
98
| – | – | ﹤0.01% | 4197 |
|
|
2022
Q3 | $2K | Hold |
98
| – | – | ﹤0.01% | 4212 |
|
|
2022
Q2 | $2K | Hold |
98
| – | – | ﹤0.01% | 4239 |
|
|
2022
Q1 | $2K | Hold |
98
| – | – | ﹤0.01% | 4227 |
|
|
2021
Q4 | $2K | Hold |
98
| – | – | ﹤0.01% | 4186 |
|
|
2021
Q3 | $2K | Hold |
98
| – | – | ﹤0.01% | 4137 |
|
|
2021
Q2 | $2K | Hold |
98
| – | – | ﹤0.01% | 4055 |
|
|
2021
Q1 | $2K | Buy |
+98
| New | +$2K | ﹤0.01% | 3972 |
|
|
2018
Q4 | – | Sell |
-176
| Closed | -$1K | – | 4167 |
|
|
2018
Q3 | $1K | Buy |
+176
| New | +$1K | ﹤0.01% | 4059 |
|